Bakavičius Arnas, Barisienė Marija, Snicorius Marius, Valančienė Dileta, Dasevičius Darius, Žalimas Algirdas, Kvaščevičius Robertas, Ramonas Henrikas, Sokolovas Vitalijus, Jankevičius Feliksas
Centre of Urology, Vilnius University, Vilnius, Lithuania.
National Cancer Institute, Vilnius, Lithuania.
Acta Med Litu. 2018;25(1):31-37. doi: 10.6001/actamedica.v25i1.3701.
Mixed epithelial and stromal tumour of the kidney (MEST) is a rare and distinctive neoplasm accounting for 0.2% of all renal cancers. Most of these tumours behave in a benign fashion but 13 cases with malignant transformation have already been reported. We present the first case of an extremely aggressive MEST with rapid recurrence after radical treatment, demonstrating objective response to chemotherapy.
A 31-year-old female presented to the hospital complaining of gross hematuria. Computed tomography (CT) revealed an intraparenchymal mass in the left kidney forming a tumour thrombus in the inferior vena cava (IVC). Metastatic disease was ruled out and, under the clinical diagnosis of renal cell carcinoma, left radical nephrectomy with IVC thrombectomy was performed. The histopathological examination confirmed malignant MEST of the kidney. At the follow-up 12 months after surgery, a recurrent tumour in the left paravertebral area and a tumour thrombus in the IVC were detected. A second surgery was recommended and the mass from the paravertebral area was removed, so resection of the IVC with prosthetic replacement was performed. The histopathologic examination confirmed a recurrent malignant MEST. At the follow-up three months after the second surgery disease progression was diagnosed, so chemotherapy with ifosfamide and doxorubicin was initiated. The CT scan performed 14 months after the chemotherapy confirmed a stable process of the disease with no signs of progression.
A literature review and our case report confirm the existence of extremely aggressive malignant MEST that shows response to chemotherapy. However, more reports are needed to improve our understanding about the biology of the MEST to develop any recommendations on personalized therapy.
肾混合上皮和间质肿瘤(MEST)是一种罕见且独特的肿瘤,占所有肾癌的0.2%。这些肿瘤大多表现为良性,但已有13例发生恶性转化的病例报道。我们报告首例根治性治疗后迅速复发的极具侵袭性的MEST病例,显示出对化疗的客观反应。
一名31岁女性因肉眼血尿入院。计算机断层扫描(CT)显示左肾实质内肿块,并在下腔静脉(IVC)形成肿瘤血栓。排除转移性疾病后,在肾细胞癌的临床诊断下,进行了左肾根治性切除术及IVC血栓切除术。组织病理学检查证实为肾恶性MEST。术后12个月随访时,在左椎旁区域发现复发性肿瘤及IVC内肿瘤血栓。建议进行二次手术,切除椎旁区域肿块,并进行IVC人工血管置换切除。组织病理学检查证实为复发性恶性MEST。二次手术后3个月随访时诊断疾病进展,因此开始用异环磷酰胺和阿霉素进行化疗。化疗后14个月进行的CT扫描证实疾病稳定,无进展迹象。
文献回顾及我们的病例报告证实存在对化疗有反应的极具侵袭性的恶性MEST。然而,需要更多报告以增进我们对MEST生物学特性的了解,从而制定个性化治疗建议。